Skip to content
10-Q

Quarterly Report

Evolutionary Genomics, Inc.

0001553350-20-000420

← back to feed
Filed
May 12, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2020 · Mar 31, 2020 5.88M sh
Short Term Investments Q1 2020 · Mar 31, 2020 $29.69K
Short Term Investments Q1 2020 · Dec 31, 2019 $41.69K
Current Liabilities Q1 2020 · Mar 31, 2020 $133.58K
Current Liabilities Q1 2020 · Dec 31, 2019 $19.42K
Total Liabilities Q1 2020 · Mar 31, 2020 $1.12M
Total Liabilities Q1 2020 · Dec 31, 2019 $1.01M
Current Assets Q1 2020 · Mar 31, 2020 $55.62K
Current Assets Q1 2020 · Dec 31, 2019 $118.16K
Total Assets Q1 2020 · Mar 31, 2020 $4.17M
Total Assets Q1 2020 · Dec 31, 2019 $4.24M
Operating Cash Flow Q1 2020 · Mar 31, 2019 −$124.08K
Cash And Equivalents Q1 2020 · Mar 31, 2019 $7.33K
Cash And Equivalents Q1 2020 · Dec 31, 2018 $131.41K
Stockholders Equity Q1 2020 · Mar 31, 2019 $220.47K
Stockholders Equity Q1 2020 · Dec 31, 2018 $403.59K
Sga Expense Q1 2020 · Mar 31, 2019 $58.25K
Rd Expense Q1 2020 · Mar 31, 2019 $131.68K
Net Income Q1 2020 · Mar 31, 2019 −$200.4K
Operating Income Q1 2020 · Mar 31, 2019 −$212.35K
Revenue Q1 2020 · Mar 31, 2019 $32.37K